Area of research
Surgery · Pathology and Forensic Medicine
Research interest
Research interests include Esophageal Cancer Research and Treatment, Genetic factors in colorectal cancer, Gastric Cancer Management and Outcomes, and Cancer Genomics and Diagnostics.
Evolutionary and immune microenvironment dynamics during neoadjuvant treatment of esophageal adenocarcinoma
Low-coverage whole genome sequencing of low-grade dysplasia strongly predicts advanced neoplasia risk in ulcerative colitis
212 Research Priorities for Cancers of the Oesophagus and Stomach: Recommendations from a United Kingdom & Ireland Patient and Healthcare Professional Partnership Exercise
Homopolymer switches mediate adaptive mutability in mismatch repair-deficient colorectal cancer
Diagnosis and management of Barrett esophagus: European Society of Gastrointestinal Endoscopy (ESGE) Guideline
The Tissue Systems Pathology Test Outperforms Pathology Review in Risk Stratifying Patients With Low-Grade Dysplasia
Data from Practical and Robust Identification of Molecular Subtypes in Colorectal Cancer by Immunohistochemistry
Immunosuppressive niche engineering at the onset of human colorectal cancer
Analysis of metastases rates during follow-up after endoscopic resection of early “high-risk” esophageal adenocarcinoma
Endoscopic tissue sampling – Part 1: Upper gastrointestinal and hepatopancreatobiliary tracts. European Society of Gastrointestinal Endoscopy (ESGE) Guideline
Endoscopic tissue sampling – Part 2: Lower gastrointestinal tract. European Society of Gastrointestinal Endoscopy (ESGE) Guideline
British Society of Gastroenterology guidelines on the diagnosis and management of patients at risk of gastric adenocarcinoma
Undifferentiated Sarcomas Develop through Distinct Evolutionary Pathways
The evolutionary landscape of colorectal tumorigenesis
Practical and Robust Identification of Molecular Subtypes in Colorectal Cancer by Immunohistochemistry
Pan-cancer analysis of the extent and consequences of intratumor heterogeneity
Identification of Patients With Variants in TPMT and Dose Reduction Reduces Hematologic Events During Thiopurine Treatment of Inflammatory Bowel Disease
Abstract LB-108: Automated immunohistochemistry-based identification of molecular subtypes in colorectal cancer
Quantification of Crypt and Stem Cell Evolution in the Normal and Neoplastic Human Colon